Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.

More than half of patients with high-risk myelodysplastic syndrome may not be receiving guideline-recommended treatment with ...

2.4-cm, grade 2, node-negative invasive ductal carcinoma (IDC), HR positive, HER2 immunohistochemistry (IHC) 1+, Ki-67 20% of ...

The neurodegenerative disease damages patients’ motor, cognitive and behavioral controls, which sometimes manifest as ...

The Italian drugmaker will pay as much as $115 million in upfront and near-term payments in a deal that gives it rights to a ...